The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

About
Science 37.

Science 37 enables universal access to clinical research—making it easier for patients and providers to participate and accelerating the development of new and innovative treatments that impact patient lives. With the industry’s first and only, technology-first Decentralized Clinical Trial Operating System™ (DCT OS), we enable workflow orchestration, evidence generation and data harmonization on a unified, seamless platform—configurable to enable any study and fused with our expansive networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.

Science 37

We make clinical research more human and accessible.
When you achieve that, the results are extraordinary.

Science 37 Leadership.

David Coman
David Coman
Chief Executive Officer
Chris Ceppi
Chris Ceppi
Chief Product Officer
Jonathan Cotliar
Jonathan Cotliar
Chief Medical Officer
Darcy Forman
Darcy Forman
Chief Delivery Officer
Drew Bustos
Drew Bustos
Chief Strategy and Marketing Officer
Steve Geffon
Steve Geffon
Chief Commercial Officer
Mike Zaranek
Mike Zaranek
Chief Financial Officer
Jim Young
Jim Young
Chief Human Resources Officer
Laura Podolsky
Laura Podolsky
General Counsel
Anita Modi
Anita Modi
VP, Business Transformation

Science 37 Investors & Partners.

  • Amgen
  • Boehringer-Ingelheim
  • DXR
  • Genentech
  • Glynn Capital
  • GV
  • Janssen
  • Lux
  • Novartis
  • PPD
  • Redmile Group
  • Sanofi
  • UCB